Perspectives on Using Physcomitrella Patens as an Alternative Production Platform for Thapsigargin and Other Terpenoid Drug Candidates
Perspectives in Medicinal Chemistry · 2009
DOI: 10.4137/pmc.s2220 ↗Kurz gefasst
Fachartikel in der Zeitschrift Perspectives in Medicinal Chemistry, 2009. Verfasst von Henrik Toft Simonsen und 2 weiteren Autor:innen. Beteiligte Einrichtung: VKR Research Centre Pro-Active Plants, Department of Plant Biology and Biotechnology, Faculty of Life Sciences, University of Copenhagen, Thorvaldsen…. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
To overcome the potential future demand for terpenoids used as drugs, a new production platform is currently being established in our laboratory. The moss Physcomitrella has been chosen as the candidate organism for production of drug candidates based on terpenoids derived from plants, with a primary focus on the sesquiterpene lactone, thapsigargin. This drug candidate and other candidates/drugs with sesquiterpene skeleton are difficult to obtain by chemical synthesis due to their large number of chiral centers. Furthermore, they are not available in sufficient amounts from their original plant. The requirement for a new production system to meet the potential market demand for these compounds is not only obvious, but also essential if sufficient quantities of the drug candidates are to be available for the potential therapeutic use.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- VKR Research Centre Pro-Active Plants, Department of Plant Biology and Biotechnology, Faculty of Life Sciences, University of Copenhagen, Thorvaldsensvej 40, 1871 Frederiksberg C, Denmark.
Zitieren
APA
Simonsen, H. T., Drew, D. P., & Lunde, C. (2009). Perspectives on Using Physcomitrella Patens as an Alternative Production Platform for Thapsigargin and Other Terpenoid Drug Candidates. Perspectives in Medicinal Chemistry. https://doi.org/10.4137/pmc.s2220
Vancouver
Simonsen HT, Drew DP, Lunde C. Perspectives on Using Physcomitrella Patens as an Alternative Production Platform for Thapsigargin and Other Terpenoid Drug Candidates. Perspectives in Medicinal Chemistry. 2009. doi:10.4137/pmc.s2220
BibTeX
@article{Simonsen2009,
author = {Simonsen, Henrik Toft and Drew, Damian Paul and Lunde, Christina},
title = {Perspectives on Using Physcomitrella Patens as an Alternative Production Platform for Thapsigargin and Other Terpenoid Drug Candidates},
journal = {Perspectives in Medicinal Chemistry},
year = {2009},
doi = {10.4137/pmc.s2220}
}
EUVIMED